PTCT - Ptc Therapeutics, Inc.

Insider Sale by Okey Stephanie (Dir)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, Okey Stephanie, serving as Dir at Ptc Therapeutics, Inc. (PTCT), sold 15,167 shares at $70.00 per share, for a total transaction value of $1,061,690.00. Following this transaction, Okey Stephanie now holds 8,000 shares of PTCT.

This sale represents a 65.00% decrease in Okey Stephanie's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, March 10, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 12, 2026, 2 days after the trade was made.

Ptc Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Okey Stephanie

Dir

Stephanie S. Okey, M.S. is an independent director at Crinetics Pharmaceuticals, Inc. (CRNX), appointed in July 2019.[[1]](https://www.globenewswire.com/news-release/2019/07/16/1883384/0/en/Crinetics-Pharmaceuticals-Appoints-Stephanie-Okey-to-Board-of-Directors.html)[[2]](https://fintool.com/app/research/companies/CRNX/people/stephanie-okey)[[3]](https://crinetics.com/stephanie-okey-appointed-to-board-of-directors/) With over 25 years in biopharma, she held senior roles at Genzyme (including SVP, Head of North America Rare Diseases and U.S. General Manager Rare Diseases for 19 years), Genentech (nearly 8 years in sales and marketing), and Bristol Myers Squibb.[[1]](https://www.globenewswire.com/news-release/2019/07/16/1883384/0/en/Crinetics-Pharmaceuticals-Appoints-Stephanie-Okey-to-Board-of-Directors.html)[[2]](https://fintool.com/app/research/companies/CRNX/people/stephanie-okey) Her expertise spans commercialization of rare and orphan diseases, including endocrine disorders like Gaucher, Fabry, Pompe, and others.[[1]](https://www.globenewswire.com/news-release/2019/07/16/1883384/0/en/Crinetics-Pharmaceuticals-Appoints-Stephanie-Okey-to-Board-of-Directors.html)[[3]](https://crinetics.com/stephanie-okey-appointed-to-board-of-directors/) Okey serves on boards of PTC Therapeutics (since 2018), City of Hope Medical Center (since 2024), and previously Albireo Pharma (2018-2023), Orphazyme (2021-2022), and Catalent (2023-2024).[[2]](https://fintool.com/app/research/companies/CRNX/people/stephanie-okey)[[8]](https://theorg.com/org/city-of-hope/org-chart/stephanie-s-okey) She holds a B.S. in Zoology from The Ohio State University and an M.S. in Immunology and Medical Microbiology from Wright State University.[[1]](https://www.globenewswire.com/news-release/2019/07/16/1883384/0/en/Crinetics-Pharmaceuticals-Appoints-Stephanie-Okey-to-Board-of-Directors.html)[[2]](https://fintool.com/app/research/companies/CRNX/people/stephanie-okey) Recently, as CRNX director (age 65), she sold 3,000 shares on March 3, 2026, under a Rule 10b5-1 plan, retaining 13,300 shares.[[4]](https://www.stocktitan.net/sec-filings/CRNX/form-4-crinetics-pharmaceuticals-inc-insider-trading-activity-8444c8c6bf97.html)[[6]](https://www.gurufocus.com/news/8679123/insider-sell-stephanie-okey-sells-3000-shares-of-crinetics-pharmaceuticals-inc-crnx)

View full insider profile →

Trade Price

$70.00

Quantity

15,167

Total Value

$1,061,690.00

Shares Owned

8,000

Trade Date

Tuesday, March 10, 2026

5 days ago

SEC Filing Date

Thursday, March 12, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Ptc Therapeutics, Inc.

Company Overview

No company information available
View news mentioning PTCT

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4725053

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime